RegenETP Statistics
Total Valuation
RegenETP has a market cap or net worth of 1.17 million.
Market Cap | 1.17M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
RegenETP has 7.19 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 7.19M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +1.14% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.00% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 17.54 |
PB Ratio | 0.09 |
P/TBV Ratio | 0.09 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.24.
Current Ratio | 4.11 |
Quick Ratio | 3.15 |
Debt / Equity | 0.24 |
Debt / EBITDA | n/a |
Debt / FCF | -0.14 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.97% and return on invested capital (ROIC) is -76.30%.
Return on Equity (ROE) | -54.97% |
Return on Assets (ROA) | -56.67% |
Return on Invested Capital (ROIC) | -76.30% |
Return on Capital Employed (ROCE) | -137.33% |
Revenue Per Employee | 1,698 |
Profits Per Employee | -193,140 |
Employee Count | 43 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +193.83% in the last 52 weeks. The beta is 2.90, so RegenETP's price volatility has been higher than the market average.
Beta (5Y) | 2.90 |
52-Week Price Change | +193.83% |
50-Day Moving Average | 0.15 |
200-Day Moving Average | 0.13 |
Relative Strength Index (RSI) | 65.11 |
Average Volume (20 Days) | 2,258 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.67 |
Income Statement
In the last 12 months, RegenETP had revenue of 73,000 and -8.31 million in losses. Loss per share was -1.09.
Revenue | 73,000 |
Gross Profit | -52,000 |
Operating Income | -21.80M |
Pretax Income | -8.31M |
Net Income | -8.31M |
EBITDA | -20.60M |
EBIT | -21.80M |
Loss Per Share | -1.09 |
Balance Sheet
The company has 6.39 million in cash and 2.95 million in debt, giving a net cash position of 3.44 million or 0.48 per share.
Cash & Cash Equivalents | 6.39M |
Total Debt | 2.95M |
Net Cash | 3.44M |
Net Cash Per Share | 0.48 |
Equity (Book Value) | 12.42M |
Book Value Per Share | 1.74 |
Working Capital | 6.76M |
Cash Flow
In the last 12 months, operating cash flow was -21.64 million and capital expenditures -6,000, giving a free cash flow of -21.64 million.
Operating Cash Flow | -21.64M |
Capital Expenditures | -6,000 |
Free Cash Flow | -21.64M |
FCF Per Share | -3.01 |
Margins
Gross Margin | -71.23% |
Operating Margin | -29,868.49% |
Pretax Margin | -11,376.71% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RegenETP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -139.08% |
Shareholder Yield | -139.08% |
Earnings Yield | -707.00% |
FCF Yield | -1,842.38% |
Stock Splits
The last stock split was on May 17, 2022. It was a reverse split with a ratio of 0.04.
Last Split Date | May 17, 2022 |
Split Type | Reverse |
Split Ratio | 0.04 |
Scores
RegenETP has an Altman Z-Score of -43.11. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -43.11 |
Piotroski F-Score | n/a |